Biotech veteran of +20 years with +15 years in diagnostic startups
Launched 3 diagnostic products from concept to commercialization
Leader at 5 diagnostic companies with 3 successful exits
Our Mission
We’re on a mission to revolutionize disease screening through noninvasive urine spectroscopy and artificial intelligence
Awards
FIRST PLACE
Within the Association of Diagnostic and Laboratory Medicine (ADLM), we proudly secured victory in the DxPx 42PLUS1 competition, sponsored by Mayo Clinic, standing out among approximately 100 applicants.
LEAP RECIPIENT
Selected by McDermott for its groundbreaking innovation in life sciences, receiving exclusive access to world-class legal expertise and strategic resources to accelerate our growth and impact in cancer detection.
Massachusetts AI Health Innovation (MAHI) Grant
Awarded by the Cambridge Innovation Center (CIC), this grant enables their expert team to collaborate with us on software development, advancing AI-powered cancer screening.
Our Values
Accuracy
Strive for the highest level of accuracy and precision to ensure reliable results for patients and healthcare providers
Compassion
Show empathy and compassion for individuals undergoing screening, recognizing the sensitivity and anxiety associated with medical tests
Innovation
Foster a culture of continuous innovation, always seeking new and improved methods to enhance the accuracy and convenience of diagnostics
Integrity
Uphold the highest ethical standards in all interactions, from data privacy and patient confidentiality to business practices and research
Patient First
Prioritize the well-being, comfort, and convenience of patients, ensuring that their needs are at the forefront of all decision-making processes
Scientific Rigor
Commit to rigorous scientific methodologies, including peer-reviewed research, clinical trials, and validation studies, to ensure the reliability of diagnostic methods
Co-Founders & Leadership
Matthew Laskowski, MSc
Chief Executive Officer
Technology expert with +6 years of Strategy & Operations experience
Launched GTMs for +10 products in FinTech and SaaS
Leader at 2 high-growth tech companies
Mark November
Executive Leader
Decades of experience in startups
Co-Founder of Venture Starters, the largest startup community of startups and investors meeting weekly
Is a co-founder of numerous companies, sits on numerous boards, and successful in multiple industries
The Story
Over time, Dragan became disillusioned with sequencing and was in search of an alternative technology. After a +5-year diagnostic journey for an uncommon autoimmune disease, Matthew discovered an alternative data-driven approach that he would have liked to use for himself. Together, we discovered that these two puzzle pieces (Dragan’s problem and Matthew’s solution) fit together perfectly and that we shared the same goal. We named our company Toby, after Sherlock Holmes's bloodhound.
Team
Jackie Magno, MSM
Advisor
Operating Committee Chair and Managing Director for Golden Seeds Silicon Valley for +13 years
Wen-Yee Lee, Prof
Advisor
Research in GC-MS for +20 years and VOCs for prostate cancer detection for +6 years
Collaborators
Duke Cancer Institute
Collaborator
Collaborator for our Clinical Utility Study and Clinical Validation Study
University of South Alabama
Collaborator
Perfect demographic with interest in kidney, bladder, breast, lung, and stomach cancer
MassChallenge
Highly Ranked Acccelerator
Chosen from +1,300 applicants for the highly ranked remote and equity-free accelerator